bpc 157 prostate cancer | Gastric Pentadecapeptide Body Protecting Compound 157 (BPC-157
Description
BPC-157 has shown no significant toxicity even at doses far exceeding therapeutic ranges across numerous animal studies
This can help differentiate between granulomatous reactions, infections, and other possible causes of the nodules
Others suggest it modulates gastric motility through effects on myenteric plexus neurons
If it takes significantly longer, the powder may have been exposed to moisture or temperature extremes before reconstitution
Amazing results
Separation or layering The solution should be homogeneous, meaning the same throughout
